Stay in Step With Treatments for Restless Legs Syndrome

July 2025

Dopamine agonists (ropinirole, etc) are no longer first-line for restless legs syndrome (RLS)...according to the Am Acad of Sleep Medicine.

We’re used to reaching for these meds to help RLS symptoms quickly.

Now recent guidelines conditionally recommend AGAINST their use unless patients are prioritizing short-term benefits over long-term risks.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote